{"filing":{"accession_number":"0000885725-26-000061","cik":"0000885725","ticker":"BSX","company_name":"BOSTON SCIENTIFIC CORP","form":"8-K","filing_date":"2026-09-23","report_date":"2026-09-21","primary_document":"bsx-20260921.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/885725/000088572526000061/bsx-20260921.htm"},"events":[{"id":34440,"run_id":31684,"accession_number":"0000885725-26-000061","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"Arthur C. Butcher, Executive Vice President and Group President of MedSurg and Asia Pacific, is retiring effective January 1, 2027, with a transition period as senior advisor through February 26, 2027. While the filing mentions compensatory arrangements (base salary continuation and retirement benefits), the principal disclosed action is Butcher's departure from his executive role. The retirement of a senior executive overseeing significant business segments (MedSurg and Asia Pacific) is material to investors assessing management continuity and operational leadership.","company_name":"BOSTON SCIENTIFIC CORP","ticker":"BSX","filing_date":"2026-09-23","form":"8-K","submitted_at":null,"items":[{"id":38162,"accession_number":"0000885725-26-000061","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Arthur C. Butcher, Executive Vice President and Group President of MedSurg and Asia Pacific, is retiring effective January 1, 2027, with a transition period as senior advisor through February 26, 2027. While the filing mentions compensatory arrangements (base salary continuation and retirement benefits), the principal disclosed action is Butcher's departure from his executive role. The retirement of a senior executive overseeing significant business segments (MedSurg and Asia Pacific) is material to investors assessing management continuity and operational leadership.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T10:05:54.560001+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38162,"accession_number":"0000885725-26-000061","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Arthur C. Butcher, Executive Vice President and Group President of MedSurg and Asia Pacific, is retiring effective January 1, 2027, with a transition period as senior advisor through February 26, 2027. While the filing mentions compensatory arrangements (base salary continuation and retirement benefits), the principal disclosed action is Butcher's departure from his executive role. The retirement of a senior executive overseeing significant business segments (MedSurg and Asia Pacific) is material to investors assessing management continuity and operational leadership.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T10:05:54.560001+00:00","company_name":"BOSTON SCIENTIFIC CORP","ticker":"BSX","filing_date":"2026-09-23"}]}